Skip to main content

Advertisement

BMC journals have moved to Springer Nature Link. Learn more about website changes.
Springer Nature Link
Account
Menu
Find a journal Publish with us Track your research
Search
Saved research
Cart
  1. Home
  2. BMC Pulmonary Medicine
  3. Article

Development and validation of a risk prediction model for severe community-acquired pneumonia associated pulmonary embolism

  • Research
  • Open access
  • Published: 21 October 2026
  • Cite this article

You have full access to this open access article

Download PDF
View saved research
BMC Pulmonary Medicine Aims and scope Submit manuscript
Development and validation of a risk prediction model for severe community-acquired pneumonia associated pulmonary embolism
Download PDF
  • Bingqian Zeng1,
  • Jiawang Wu1,
  • Ting Liu1,
  • Xinting Zhang1,
  • Chongchang Qu1,
  • Linxin Zheng1,
  • Ningyuan Zhang1,
  • Shuanglan Xu1,
  • Jiao Yang2 &
  • …
  • Xiqian Xing1 
  • 29 Accesses

  • Explore all metrics

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Background

Pulmonary embolism (PE) may be difficult to detect in patients with severe community-acquired pneumonia (SCAP) because symptoms and physiological abnormalities overlap with those of severe infection and respiratory failure. Early identification of patients at high risk of PE may facilitate timely diagnostic evaluation. This study aimed to identify factors associated with PE among patients with SCAP admitted to the intensive care unit (ICU) and to establish and validate a nomogram for identifying those at high risk of PE.

Methods

Clinical data from 3148 ICU patients with SCAP were retrospectively analyzed using the Medical Information Mart for Intensive Care IV (MIMIC-IV, version 2.2; 2008–2019) database. A random 7:3 split was used to form the training cohort (n = 2204) and validation cohort (n = 944). Independent predictors were determined by least absolute shrinkage and selection operator followed by multivariable logistic regression, and these predictors were used to build a nomogram. The model was assessed in terms of discrimination, calibration, and clinical net benefit using the area under the receiver operating characteristic curve (AUROC), calibration curves and Brier scores, and decision curve analysis (DCA), respectively.

Results

Among the 3148 ICU patients with SCAP, PE was identified in 152 patients (4.83%). Age, sex, heart rate, creatinine, prothrombin time, activated partial thromboplastin time, and partial pressure of oxygen were independently associated with PE in patients with SCAP. The model achieved AUROC values of 0.683 (95% CI, 0.635–0.731) in the training cohort and 0.658 (95% CI, 0.567–0.749) in the validation cohort. The Brier scores were 0.0464 and 0.0416 in the training and validation cohorts, respectively, and the calibration curves showed good consistency between predicted and observed risks. Bootstrap internal validation with 1000 resamples yielded an optimism-corrected AUROC of 0.661. DCA indicated a clinical net benefit for threshold probabilities of approximately 0.03–0.15.

Conclusions

This study constructed the first model for estimating PE risk among ICU patients with SCAP and validated its performance. The model demonstrated modest discrimination and good calibration and may facilitate early PE risk assessment and stratification in this population. However, its predictive performance and clinical applicability require further validation in independent external cohorts.

Trial registration

Not applicable. This study is a retrospective observational analysis based on the MIMIC-IV database.

Similar content being viewed by others

Incidence and risk factor of sepsis in patients with severe community-acquired pneumonia: a Chinese, single-center, retrospective study

Article Open access 02 May 2025

A clinically interpretable prediction model for acute mortality in patients with pneumonia requiring mechanical ventilation

Article Open access 23 February 2026

Interpretable prediction model for severe community-acquired pneumonia in adults: machine learning development and validation using routine laboratory parameters

Article Open access 29 July 2026

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.
  • Physical examination
  • Thromboembolism
  • Risk Factors
  • Phlebology
  • Diagnosis
  • Idiopathic thrombocytopaenic purpura
  • Pulmonary Embolism Diagnosis and Management

Abbreviations

SCAP:

Severe community-acquired pneumonia

PE:

Pulmonary embolism

ICU:

Intensive care unit

MIMIC-IV:

Medical Information Mart for Intensive Care IV

AUROC:

Area under the receiver operating characteristic curve

DCA:

Decision curve analysis

CAP:

Community-acquired pneumonia

VTE:

Venous thromboembolism

DVT:

Deep vein thrombosis

COVID-19:

Coronavirus disease 2019

BIDMC:

Beth Israel Deaconess Medical Center

IRB:

Institutional Review Board

ICD-CM:

International Classification of Diseases, Clinical Modification

ICU-LOS:

ICU length of stay

Hospital-LOS:

Hospital length of stay

SBP:

Systolic blood pressure

DBP:

Diastolic blood pressure

MAP:

Mean arterial pressure

SpO2 :

Peripheral oxygen saturation

BUN:

Blood urea nitrogen

UCR:

Urea nitrogen to creatinine ratio

WBC:

White blood cell count

PLT:

Platelet count

CRP:

C-reactive protein

INR:

International normalized ratio

PT:

Prothrombin time

APTT:

Activated partial thromboplastin time

Lac:

Lactate

HCO₃⁻:

Bicarbonate

PCO2 :

Partial pressure of carbon dioxide

PO2 :

Partial pressure of oxygen

CHF:

Congestive heart failure

SIRS:

Systemic Inflammatory Response Syndrome Score

SAPS II:

Simplified Acute Physiological Score II

GCS:

Glasgow Coma Scale

SOFA:

Sequential Organ Failure Assessment Score

IQR:

Interquartile range

LASSO:

Least absolute shrinkage and selection operator

λ:

Lambda

AIC:

Akaike information criterion

ORs:

Odds ratios

CIs:

Confidence intervals

RCS:

Restricted cubic spline

VIF:

Variance inflation factor

MSEP:

Mean squared error for the probability of a binary outcome

CTPA:

Computed tomography pulmonary angiography

Acknowledgements

The authors sincerely thank all contributors involved in the development and maintenance of the MIMIC-IV database for their valuable efforts and support.

Funding

This study was supported by grants from the National Natural Science Foundation of China (82560078 and 82660019), Yunnan Province’s Xingdian Talent Support Program Medical and Health Talents Special Project (No. XDYC-YLWS-2023-0043), Yunnan Province’s Xingdian Talent Support Program Special Project for Young Talents (No. XDYC-QNRC-2025-078), Yunnan Provincial Innovation Team for Respiratory and Pulmonary Circulation Diseases (No. 202405AS350018), the Yunnan Fundamental Research Projects (202501CF070056 and 202601BF070001-057), Yunnan University Fund for Medical Research (No. YDYXJJ2024-0034), and Yunnan Major Science and Technological Project (No. 202502AA310030).

Author information

Authors and Affiliations

  1. Department of Pulmonary and Critical Care Medicine, The Affiliated Hospital of Yunnan University, Key Laboratory of Respiratory Disease Research of Department of Education of Yunnan Province, Kunming, Yunnan, 650021, China

    Bingqian Zeng, Jiawang Wu, Ting Liu, Xinting Zhang, Chongchang Qu, Linxin Zheng, Ningyuan Zhang, Shuanglan Xu & Xiqian Xing

  2. Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, China

    Jiao Yang

Authors
  1. Bingqian Zeng
    View author publications

    Search author on:PubMed Google Scholar

  2. Jiawang Wu
    View author publications

    Search author on:PubMed Google Scholar

  3. Ting Liu
    View author publications

    Search author on:PubMed Google Scholar

  4. Xinting Zhang
    View author publications

    Search author on:PubMed Google Scholar

  5. Chongchang Qu
    View author publications

    Search author on:PubMed Google Scholar

  6. Linxin Zheng
    View author publications

    Search author on:PubMed Google Scholar

  7. Ningyuan Zhang
    View author publications

    Search author on:PubMed Google Scholar

  8. Shuanglan Xu
    View author publications

    Search author on:PubMed Google Scholar

  9. Jiao Yang
    View author publications

    Search author on:PubMed Google Scholar

  10. Xiqian Xing
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Shuanglan Xu, Jiao Yang or Xiqian Xing.

Ethics declarations

Ethics approval and consent to participate

All patient information in the database was fully de-identified, and the establishment of the MIMIC-IV database had been approved by the IRB of BIDMC (No. 2001P001699). Therefore, additional ethical review for the present study was not required.

Consent for publication

All authors have read and approved the final manuscript and consent to its publication.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1 (download DOCX )

Supplementary Material 2: Supplementary Table 1 (download DOCX )

Supplementary Material 3: Supplementary Table 2 (download DOCX )

Supplementary Material 4: Supplementary Table 3 (download XLSX )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zeng, B., Wu, J., Liu, T. et al. Development and validation of a risk prediction model for severe community-acquired pneumonia associated pulmonary embolism. BMC Pulm Med (2026). https://doi.org/10.1186/s12890-026-04878-9

Download citation

  • Received: 16 September 2025

  • Accepted: 16 October 2026

  • Published: 21 October 2026

  • DOI: https://doi.org/10.1186/s12890-026-04878-9

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Severe community-acquired pneumonia
  • Pulmonary embolism
  • Risk prediction
  • Intensive care unit
  • Nomogram

Advertisement

Search

Navigation

  • Find a journal
  • Publish with us
  • Track your research

Footer Navigation

Discover content

  • Journals A-Z
  • Books A-Z
  • Subjects A-Z

Publish with us

  • Journal finder
  • Publish your research
  • Language editing
  • Open access publishing

Products and services

  • Our products
  • Librarians
  • Societies
  • Partners and advertisers

Our brands

  • Springer
  • Nature Portfolio
  • BMC
  • Palgrave Macmillan
  • Apress
  • Discover

Corporate Navigation

  • Your US state privacy rights
  • Accessibility statement
  • Terms and conditions
  • Privacy policy
  • Help and support
  • Legal notice
  • Cancel contracts here

Not affiliated

Springer Nature

© 2026 Springer Nature